Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 1
1981 1
1983 1
1985 2
1986 4
1987 2
1988 1
1989 2
1991 6
1992 7
1994 4
1995 4
1996 2
1997 1
1998 5
1999 8
2000 5
2001 3
2002 6
2003 6
2004 5
2005 4
2006 13
2007 2
2008 7
2009 2
2010 6
2011 10
2012 6
2013 9
2014 9
2015 14
2016 14
2017 12
2018 9
2019 8
2020 4
2021 14
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management.
Tefferi A. Tefferi A. Am J Hematol. 2023 May;98(5):801-821. doi: 10.1002/ajh.26857. Epub 2023 Feb 6. Am J Hematol. 2023. PMID: 36680511 Free article. Review.
Approximately 15% of patients with ET or polycythemia vera (PV) might progress into post-ET/PV MF. MUTATIONS: SRSF2, ASXL1, and U2AF1-Q157 mutations predict inferior survival in PMF; RAS/CBL mutations predict resistance to ruxolitinib therapy. ...RISK STRATIFICATION …
Approximately 15% of patients with ET or polycythemia vera (PV) might progress into post-ET/PV MF. MUTATIONS: SRSF2, ASXL1, and U2AF1-Q157 m …
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Tefferi A. Tefferi A. Am J Hematol. 2021 Jan;96(1):145-162. doi: 10.1002/ajh.26050. Epub 2020 Dec 2. Am J Hematol. 2021. PMID: 33197049 Free article. Review.
Additional disease features include bone marrow reticulin/collagen fibrosis, aberrant inflammatory cytokine expression, anemia, hepatosplenomegaly, extramedullary hematopoiesis (EMH), constitutional symptoms, cachexia, leukemic progression, and shortened survival. . …
Additional disease features include bone marrow reticulin/collagen fibrosis, aberrant inflammatory cytokine expression, anemia, hepatospleno …
Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
Zhao L, He R, Long H, Guo B, Jia Q, Qin D, Liu SQ, Wang Z, Xiang T, Zhang J, Tan Y, Huang J, Chen J, Wang F, Xiao M, Gao J, Yang X, Zeng H, Wang X, Hu C, Alexander PB, Symonds ALJ, Yu J, Wan Y, Li QJ, Ye L, Zhu B. Zhao L, et al. Nat Med. 2018 Oct;24(10):1536-1544. doi: 10.1038/s41591-018-0205-5. Epub 2018 Oct 8. Nat Med. 2018. PMID: 30297899 Free PMC article.
Specifically, we identify CD45(+) erythroid progenitor cells (CD71(+)TER119(+); EPCs) as robust immunosuppressors. CD45(+) EPCs, induced by tumor growth-associated extramedullary hematopoiesis, accumulate in the spleen to become a major population, outnumbering regu …
Specifically, we identify CD45(+) erythroid progenitor cells (CD71(+)TER119(+); EPCs) as robust immunosuppressors. CD45(+) EPCs, induced by …
Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
Arroyo-Crespo JJ, Armiñán A, Charbonnier D, Deladriere C, Palomino-Schätzlein M, Lamas-Domingo R, Forteza J, Pineda-Lucena A, Vicent MJ. Arroyo-Crespo JJ, et al. Int J Cancer. 2019 Oct 15;145(8):2267-2281. doi: 10.1002/ijc.32270. Epub 2019 Apr 2. Int J Cancer. 2019. PMID: 30860605 Free PMC article.
Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we observed both homogeneous (MDA-MB-231-Luc) and heterogeneous (4T1) metastatic spread to axillary lymph nodes. ...Additionally, we disc …
Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we …
Extramedullary hematopoiesis in cancer.
Barisas DAG, Choi K. Barisas DAG, et al. Exp Mol Med. 2024 Mar;56(3):549-558. doi: 10.1038/s12276-024-01192-4. Epub 2024 Mar 5. Exp Mol Med. 2024. PMID: 38443597 Free PMC article. Review.
Hematopoiesis can occur outside of the bone marrow during inflammatory stress to increase the production of primarily myeloid cells at extramedullary sites; this process is known as extramedullary hematopoiesis (EMH). As observed in a broad range of hematolog …
Hematopoiesis can occur outside of the bone marrow during inflammatory stress to increase the production of primarily myeloid cells at extra …
Fat-containing pelvic lesions in females.
Fattahi N, Moeini A, Morani AC, Elsayes KM, Bhosale HR, Badawy M, Menias CO, Rezvani M, Gaballah AH, Shaaban AM. Fattahi N, et al. Abdom Radiol (NY). 2022 Jan;47(1):362-377. doi: 10.1007/s00261-021-03299-y. Epub 2021 Oct 21. Abdom Radiol (NY). 2022. PMID: 34673996 Review.
The clinical management of pelvic tumors varies widely-from observation to surgical resection-and imaging plays a pivotal role in diagnosis and clinical decision-making in these cases. ...However, the imaging diagnosis of pelvic masses containing minimal or microscopic fat …
The clinical management of pelvic tumors varies widely-from observation to surgical resection-and imaging plays a pivotal role in dia …
The Effects of Sclerostin on the Immune System.
Donham C, Manilay JO. Donham C, et al. Curr Osteoporos Rep. 2020 Feb;18(1):32-37. doi: 10.1007/s11914-020-00563-w. Curr Osteoporos Rep. 2020. PMID: 31970653 Review.
Surprisingly, B cell development in the bone marrow is influenced by Sost produced by mesenchymal stem cells and osteoblasts, but not by osteocytes. Additionally, extramedullary hematopoiesis in the spleen and increased pro-inflammatory cytokine levels in the bone m …
Surprisingly, B cell development in the bone marrow is influenced by Sost produced by mesenchymal stem cells and osteoblasts, but not by ost …
Idiopathic myelofibrosis.
Barosi G, Hoffman R. Barosi G, et al. Semin Hematol. 2005 Oct;42(4):248-58. doi: 10.1053/j.seminhematol.2005.05.018. Semin Hematol. 2005. PMID: 16210038 Review.
Idiopathic myelofibrosis (IMF) is characterized by anemia, progressive splenomegaly, bone marrow fibrosis, and extramedullary hematopoiesis. However, patients with a transitional myeloproliferative disorder (MPD), a prefibrotic form of myelofibrosis, or myelofibrosi …
Idiopathic myelofibrosis (IMF) is characterized by anemia, progressive splenomegaly, bone marrow fibrosis, and extramedullary hema …
Adrenal myelolipoma: a comprehensive review.
Decmann Á, Perge P, Tóth M, Igaz P. Decmann Á, et al. Endocrine. 2018 Jan;59(1):7-15. doi: 10.1007/s12020-017-1473-4. Epub 2017 Nov 21. Endocrine. 2018. PMID: 29164520 Review.
INTRODUCTION: Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland that is the second most common primary adrenal incidentaloma following adrenocortical adenomas. It is composed of elements of adipose tissue and extramedullary hematopoiesis. Hyp …
INTRODUCTION: Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland that is the second most common primary adrenal incid …
Thalassemia intermedia: revisited.
Taher A, Isma'eel H, Cappellini MD. Taher A, et al. Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. doi: 10.1016/j.bcmd.2006.04.005. Epub 2006 Jun 5. Blood Cells Mol Dis. 2006. PMID: 16737833 Review.
A number of clinical complications commonly associated with thalassemia intermedia are rarely seen in thalassemia major, including extramedullary hematopoiesis, leg ulcers, gallstones and thrombophilia. ...Here, we review the major clinical complications in thalasse …
A number of clinical complications commonly associated with thalassemia intermedia are rarely seen in thalassemia major, including extram …
213 results